据最新公告,颖通控股(股份代号:<6883.HK>)旗下子公司计划以人民币9750万元的对价,收购Brightday及Dream Biotechnology公司共计15%的股权。此次交易进一步拓展了集团在相关领域的战略布局。
据最新公告,颖通控股(股份代号:<6883.HK>)旗下子公司计划以人民币9750万元的对价,收购Brightday及Dream Biotechnology公司共计15%的股权。此次交易进一步拓展了集团在相关领域的战略布局。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.